King Pharmaceuticals KG Discontinued Ops Cash Flow
Discontinued Ops Cash Flow at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's discontinued ops cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's discontinued ops cash flow?
- King Pharmaceuticals (KG) reported discontinued ops cash flow of -$703.25K in Q4 2025.
- What does discontinued ops cash flow mean?
- Represents the net cash flow generated by or used in business units that have been divested or are held for sale. This metric isolates the impact of non-core or discontinued operations from the ongoing cash generation of the primary business. It is essential for investors to distinguish between recurring operational cash flows and one-time impacts from business exits.